These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9263507)

  • 21. [Peritoneal blood flow, peritoneal transfer and continuous ambulatory peritoneal dialysis].
    Grzegorzewska A; Sliwowski A
    Pol Merkur Lekarski; 1997 Sep; 3(15):122-5. PubMed ID: 9461708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human erythropoietin improves enzyme activity in erythrocytes of predialysis uremics.
    Pietrzak I; Baczyk K; Kubiak W
    Miner Electrolyte Metab; 1996; 22(1-3):102-5. PubMed ID: 8676797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statistical analysis of monitoring examinations in chronic peritoneal dialysis program.
    Balás EA; Taraba I
    Acta Med Hung; 1984; 41(4):279-85. PubMed ID: 6514481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of larger molecules on cellular response in uremia.
    Giacchino F; Quarello F; Pozzato M; Giraudo G; Formica M; Quattrocchio G; Piccoli G
    Trans Am Soc Artif Intern Organs; 1983; 29():29-32. PubMed ID: 6608816
    [No Abstract]   [Full Text] [Related]  

  • 25. Indicators of body size in peritoneal dialysis: their relation to urea and creatinine clearances.
    Tzamaloukas AH; Malhotra D; Murata GH
    Perit Dial Int; 1998; 18(4):366-70. PubMed ID: 10505556
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clearances in automated intermittent peritoneal techniques: a new formula to use morning blood sampling].
    Napoli M; De Pascalis A; Russo F; Antonaci AL; Valletta AR; Buongiorno E
    G Ital Nefrol; 2008; 25(5):562-9. PubMed ID: 18828118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of human erythrocyte transketolase: a preliminary report.
    Greenwood J; Jeyasingham M; Pratt OE; Ryle PR; Shaw GK; Thomson AD
    Alcohol Alcohol; 1984; 19(2):123-9. PubMed ID: 6497956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythrocyte transketolase activity in dialysis patients with neuropathy.
    Warnock LG; Cullum UX; Stouder DA; Stone WJ
    Biochem Med; 1974 Aug; 10(4):351-9. PubMed ID: 4851900
    [No Abstract]   [Full Text] [Related]  

  • 29. [Continuous ambulatory peritoneal dialysis].
    Pasternack A; Lampainen E; Viranta M; Huttunen K; Kunelius P; Helanterä A
    Duodecim; 1981; 97(15):1153-61. PubMed ID: 7327106
    [No Abstract]   [Full Text] [Related]  

  • 30. Erythrocyte transketolase inhibition, neuropathy and uremia.
    Henderson LW
    N Engl J Med; 1971 Jun; 284(25):1435-6. PubMed ID: 4325317
    [No Abstract]   [Full Text] [Related]  

  • 31. European best practice guidelines for peritoneal dialysis. 7 Adequacy of peritoneal dialysis.
    Dombros N; Dratwa M; Feriani M; Gokal R; Heimbürger O; Krediet R; Plum J; Rodrigues A; Selgas R; Struijk D; Verger C;
    Nephrol Dial Transplant; 2005 Dec; 20 Suppl 9():ix24-ix27. PubMed ID: 16263748
    [No Abstract]   [Full Text] [Related]  

  • 32. Blood thiamine levels in outpatients with diabetes mellitus.
    Saito N; Kimura M; Kuchiba A; Itokawa Y
    J Nutr Sci Vitaminol (Tokyo); 1987 Dec; 33(6):421-30. PubMed ID: 3451944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acid-base balance during peritoneal dialysis (intermittent PD and CAPD) with acetate and lactate].
    La Greca G; Biasoli S; Chiaramonte S; Fabris A; Feriani M; Pisani E; Ronco C; Zen F
    Minerva Nefrol; 1981; 28(3):359-64. PubMed ID: 7329615
    [No Abstract]   [Full Text] [Related]  

  • 34. Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis.
    Kihm LP; Müller-Krebs S; Klein J; Ehrlich G; Mertes L; Gross ML; Adaikalakoteswari A; Thornalley PJ; Hammes HP; Nawroth PP; Zeier M; Schwenger V
    J Am Soc Nephrol; 2011 May; 22(5):914-26. PubMed ID: 21511829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adequacy of continuous ambulatory peritoneal dialysis: comparison with other dialysis techniques.
    Ronco C; Bosch JP; Lew SQ; Feriani M; Chiaramonte S; Conz P; Brendolan A; La Greca G
    Kidney Int Suppl; 1994 Dec; 48():S18-24. PubMed ID: 7700036
    [No Abstract]   [Full Text] [Related]  

  • 36. Red cell survival and erythrocyte iron utilization in patients on continuous ambulatory peritoneal dialysis.
    Salahudeen AK; Keavey PM; Hawkins T; Wilkinson RW
    Clin Nephrol; 1984 Apr; 21(4):247-8. PubMed ID: 6733991
    [No Abstract]   [Full Text] [Related]  

  • 37. Limitations of peritoneal dialysis.
    Ronco C
    Kidney Int Suppl; 1996 Nov; 56():S69-74. PubMed ID: 8914057
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of chronic uremia by dialysis].
    Lampainen E
    Duodecim; 1983; 99(17):1218-26. PubMed ID: 6357721
    [No Abstract]   [Full Text] [Related]  

  • 39. Elevated oxidative stress measured as albumin redox state in continuous ambulatory peritoneal dialysis patients correlates with small uraemic solutes.
    Terawaki H; Matsuyama Y; Era S; Matsuo N; Ikeda M; Ogura M; Yokoyama K; Yamamoto H; Hosoya T; Nakayama M
    Nephrol Dial Transplant; 2007 Mar; 22(3):968. PubMed ID: 17071957
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dialysis of methylguanidine and hypothesis on the middle molecules].
    Barsotti G; Giovannetti S
    Ateneo Parmense Acta Biomed; 1975; 46(5):317-30. PubMed ID: 1232993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.